Biogen Chief Legal Officer Susan Alexander to depart end of May 2026
Susan H. Alexander, Chief Legal Officer of Biogen, will depart the company at the end of May 2026. The company has initiated a search for her replacement.
Biogen·18h ago·1 min read
Get S&P 500 intelligence in your inbox. Free daily newsletter.
Biogen Chief Legal Officer Susan Alexander to depart end of May 2026
Biogen's Chief Legal Officer departs after navigating the Aduhelm approval controversy and subsequent Medicare coverage restrictions — a tenure defined by regulatory and reimbursement battles that reshaped the company's Alzheimer's strategy. The <strong>end-of-May exit</strong> gives the incoming CLO a buffer before mid-year data readouts on the lecanemab label expansion.
Mar 11, 2026
Free daily newsletter delivering S&P 500 intelligence from 25+ data sources.